Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor

Surgery is the standard treatment for a primary gastrointestinal stromal tumor (GIST); however, surgical resection is often not curative, particularly for large GISTs. In the past decade, with imatinib mesylate (IM), management strategies for GISTs have evolved significantly, and now IM is the stand...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yoon, Kyu Jong, Kim, Nam Kyu, Lee, Kang Young, Min, Byung Soh, Hur, Hyuk, Kang, Jeonghyun, Lee, Sarah
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Coloproctology 2011
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3145886/
https://ncbi.nlm.nih.gov/pubmed/21829770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/jksc.2011.27.3.147
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky